Finally, to determine if the genes that display altered mRNA expression levels in ovarian cancer patient samples (PIK3CA, TTN, RYR2, KMT2C, KRAS, PTEN, and ARID1A) have any clinical value, we checked the effect of their expression on recurrence and survival of patients with ovarian cancer. This evidence concerns the gene TTN and ovarian cancer.